[HTML][HTML] Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
U Anand, A Dey, AKS Chandel, R Sanyal, A Mishra… - Genes & …, 2023 - Elsevier
Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and
produce aggressive malignancies that causes millions of deaths every year. With the new …
produce aggressive malignancies that causes millions of deaths every year. With the new …
Metallodrugs in cancer nanomedicine
Metal complexes are extensively used for cancer therapy. The multiple variables available
for tuning (metal, ligand, and metal–ligand interaction) offer unique opportunities for drug …
for tuning (metal, ligand, and metal–ligand interaction) offer unique opportunities for drug …
The side effects of platinum-based chemotherapy drugs: a review for chemists
R Oun, YE Moussa, NJ Wheate - Dalton transactions, 2018 - pubs.rsc.org
The platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in
the treatment of cancer and while they are effective, their use is limited by their severe, dose …
the treatment of cancer and while they are effective, their use is limited by their severe, dose …
A chemical perspective on the clinical use of platinum-based anticancer drugs
S Alassadi, MJ Pisani, NJ Wheate - Dalton Transactions, 2022 - pubs.rsc.org
Platinum drugs have been a mainstay of cancer chemotherapy since the introduction of
cisplatin in the 1970s. Since then, carboplatin and oxaliplatin have been approved world …
cisplatin in the 1970s. Since then, carboplatin and oxaliplatin have been approved world …
Visible‐light‐induced annihilation of tumor cells with platinum–porphyrin conjugates
A Naik, R Rubbiani, G Gasser… - Angewandte Chemie, 2014 - Wiley Online Library
Despite the extensive use of porphyrins in photodynamic therapy (PDT), tetraplatinated
porphyrins have so far not been studied for their anticancer properties. Herein, we report the …
porphyrins have so far not been studied for their anticancer properties. Herein, we report the …
Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain
HK Romero, SB Christensen… - Proceedings of the …, 2017 - National Acad Sciences
Opioids are first-line drugs for moderate to severe acute pain and cancer pain. However,
these medications are associated with severe side effects, and whether they are efficacious …
these medications are associated with severe side effects, and whether they are efficacious …
Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer
Abstract Oxaliplatin (L-OH), a platinum derivative with good tolerability is currently combined
with Cetuximab (CTX), a monoclonal antibody (mAb), for the treatment of certain (wild-type …
with Cetuximab (CTX), a monoclonal antibody (mAb), for the treatment of certain (wild-type …
[HTML][HTML] Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity
SY Yoon, CR Robinson, H Zhang, PM Dougherty - The Journal of Pain, 2013 - Elsevier
Spinal glial cells contribute to the development of many types of inflammatory and
neuropathic pain. Here the contribution of spinal astrocytes and astrocyte gap junctions to …
neuropathic pain. Here the contribution of spinal astrocytes and astrocyte gap junctions to …
An updated overview of MOF@ MIP in drug carrier and drug analysis: Construction, application and prospective
Z Guo, W Xu, G Xu, Q Jia - TrAC Trends in Analytical Chemistry, 2023 - Elsevier
The importance of drugs is well known, and researches on aspects of drugs have aroused
widespread concern. Molecularly imprinted polymers (MIPs) have the high affinity as well as …
widespread concern. Molecularly imprinted polymers (MIPs) have the high affinity as well as …
[HTML][HTML] In vitro and in vivo effects of flavonoids on peripheral neuropathic pain
P Basu, A Basu - Molecules, 2020 - mdpi.com
Neuropathic pain is a common symptom and is associated with an impaired quality of life. It
is caused by the lesion or disease of the somatosensory system. Neuropathic pain …
is caused by the lesion or disease of the somatosensory system. Neuropathic pain …